Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy-Results of a Prospective Single-Center Trial.

Authors:
Benning L; Morath C; Fink A; Rudek M; Speer C and 8 more

Journal:
Transpl Int

Publication Year: 2023

DOI:
10.3389/ti.2023.11899

PMCID:
PMC10654198

PMID:
38020751

Journal Information

Full Title: Transpl Int

Abbreviation: Transpl Int

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Transplantation

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest This study received funding from CareDx Inc. (Brisbane, CA). The funder had the following involvement with the study: funding for kits and supplies for dd-cfDNA testing."

Evidence found in paper:

"LB is funded by the Olympia Morata Program of Heidelberg University. CSp is funded by the Physician Scientist Program of the Heidelberg Faculty of Medicine. CSü is funded by the European Union’s Horizon 2020 Research and Innovation Programme (grant no. 952512). For the publication fee we acknowledge financial support by Deutsche Forschungsgemeinschaft within the funding program “Open Access Publikationskosten” as well as by Heidelberg University."

Evidence found in paper:

"Clinical Trial Registration : https://drks.de/search/de/trial/DRKS00023604 , identifier DRKS00023604."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025